Article | August 11, 2021

Innovation, Tech And Collaboration: How Advanced Material Solutions Make These Trends Realities

Cell and Gene Vaccine iStock-1296521528

The demands for flexible, scalable, cost effective manufacturing are prompting the cell and gene therapy manufacturers and CDMOs to implement techniques such as single-use technology for manufacturing their exciting therapies. From a materials perspective, however, this approach raises some challenges that require help from industry to minimize the risk of product loss or contamination. Read how advanced fluoropolymer materials can make a substantive difference in addressing these challenges.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online